Furthermore, it has been implicated in BRAF inhibitor resistance where HO-1 silencing or inhibition, using tin mesoporphyrin IX, increased sensitivity to vemurafenib, increased IL-15-activated natural killer cells, and upregulated natural killer-cell target expression enabling the improved activity of melanoma cells [188]. Here, HMOX1 is linked to melanoma.